MarketInOut Stock Screener Log In | Sign Up

Venus Remedies Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:29
Venus Remedies Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization18,586 mln
Float6.87 mln
Earnings Date02/14/2027

EPS

91.04
Exceptional

P / E

14.69
Fair value

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.82
Likely reliable

Relative Strength

7 / 100
Severely lagging

Debt / Equity

0.02
Debt-free

Business Description

Founded in 1989 and based in Panchkula, India, Venus Remedies Limited is a pharmaceutical company that operates both domestically and across global markets. The company develops and manufactures a broad range of medical treatments, including products that address infections, cancer, heart conditions, pain relief, and digestive health, among many others. A key area of focus for the company is finding new ways to combat the growing threat of antibiotic resistance.

Key Fundamentals

EPS91.04
P/E14.69
ROE18.60
RPS607
ROIC19.31
ROA14.83
Interest Cover7,400
EBITDA, mln1,779
EV / EBITDA10.49
EV / EBIT12.31
Revenue, mln8,113
EV / Revenue2.30

Quote Details

Last 1,337.00
Change -51.8 (-3.73%)
Open 1,370.00
Volume 116,125
Turnover 155,259,120
Average Volume 42,132

Financial Ratios

Pre-Tax Profit Margin19
Current Ratio3.31
Price / Book2.76
Price / Tangible Book3.14
Price / Cash Flow22.89
Price / Free Cash Flow16.26
Debt / Equity0.02
Price / Sales2.32
PEG Ratio1.88

Financial Strength

Altman Z-Score10.62
Piotroski F-Score 6 / 9
Beneish M-Score-2.82
Price to Intrinsic Value1.31
Price to Lynch Fair Value0.88
Price to Graham Number1.49
Shiller PE Ratio37.31

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -11.68% 4 / 100   
1 Month -19.86% 7 / 100   
2 Months -24.22% 13 / 100   
6 Months 43.56% 91 / 100   
1 Year 196% 99 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog